ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

American Home Products Changes Name To Wyeth.

March 1, 2002

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

“Of Sofas and Chairs” at MD Anderson: Official Seeks Protection from “Losers,” Explains Costly Interior Design Choices

June 7, 2013